Patents by Inventor Daniel Gallenkamp

Daniel Gallenkamp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARING A TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVE
    Publication number: 20230339899
    Abstract: The present invention relates to a process for preparing a tetrazole-substituted anthranilic acid diamide derivative according to formula (I) in crystalline form via solvate crystals in high purity and high yield. The present invention also further relates to the provision of novel solvate crystals which are distinguished by improved filtration properties compared to a tetrazole-substituted anthranilic acid diamide derivative according to the abovementioned formula (I) in crystalline form.
    Type: Application
    Filed: September 2, 2021
    Publication date: October 26, 2023
    Applicant: Bayer Aktiengesellschaft
    Inventors: Daniel GALLENKAMP, Edith BECKMANN, Ute ELIAS, Dirk HAVEKOST, Michal SOWA, Britta OLENIK
  • Method for preparing substituted 2,3-dihydro-1-benzofuran derivatives
    Patent number: 10710972
    Abstract: The present invention relates to a method for preparing substituted 2,3-dihydro-l-benzofuran derivatives.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: July 14, 2020
    Assignee: Bayer CropScience Aktiengesellschaft
    Inventors: Daniel Gallenkamp, Mark James Ford
  • METHOD FOR PREPARING SUBSTITUTED 2,3-DIHYDRO-1-BENZOFURAN DERIVATIVES
    Publication number: 20200190047
    Abstract: The present invention relates to a method for preparing substituted 2,3-dihydro-1-benzofuran derivatives.
    Type: Application
    Filed: August 7, 2017
    Publication date: June 18, 2020
    Inventors: Daniel GALLENKAMP, Mark James FORD
  • Method for preparing 3-substituted 2-vinylphenyl sulfonates
    Patent number: 10647667
    Abstract: The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: May 12, 2020
    Assignee: Bayer CropScience Aktiengesellschaft
    Inventors: Daniel Gallenkamp, Mark James Ford, Dirk Brohm, Florian Erver
  • METHOD FOR PREPARING 3-SUBSTITUTED 2-VINYLPHENYL SULFONATES
    Publication number: 20200071267
    Abstract: The present invention relates to a method for preparing 3-substituted 2-vinylphenyl sulfonates.
    Type: Application
    Filed: November 28, 2017
    Publication date: March 5, 2020
    Inventors: Daniel GALLENKAMP, Mark James FORD, Dirk BROHM, Florian ERVER
  • Method for producing 3-alkylsulfanyl-2-chloro-N-(1-alkyl-1H-tetrazol-5-yl)-4-trifluoromethyl-benzamides
    Patent number: 10457651
    Abstract: A method for preparing 3-alkylsulphanyl-2-chloro-N-(1-alkyl-1H-tetrazol-5-yl)-4-trifluoromethylbenzamides of the formula (I) is described. The substituents R1 and R2 therein are radicals such as alkyl and substituted phenyl.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: October 29, 2019
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Daniel Gallenkamp, Mark James Ford
  • Method for preparing substituted styrene derivatives
    Patent number: 10384995
    Abstract: The present invention relates to a method for preparing substituted styrene derivatives.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: August 20, 2019
    Assignee: BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    Inventors: Daniel Gallenkamp, Mark James Ford
  • METHOD FOR PRODUCING 3-ALKYLSULFANYL-2-CHLORO-N-(1-ALKYL-1H-TETRAZOL-5-YL)-4-TRIFLUOROMETHYL-BENZAMIDES
    Publication number: 20190233382
    Abstract: The invention relates to a method for producing 3-alkylsulfanyl-2-chloro-N-(1-alkyl-1H-tetrazol-5-yl)-4-trifluoromethyl-benzamides of formula (I). In said formula, the substituents R1 and R2 represent residues such as alkyl and substituted phenyl.
    Type: Application
    Filed: October 16, 2017
    Publication date: August 1, 2019
    Inventors: Daniel GALLENKAMP, Mark James FORD
  • METHOD FOR PREPARING SUBSTITUTED STYRENE DERIVATIVES
    Publication number: 20190177256
    Abstract: The present invention relates to a method for preparing substituted styrene derivatives.
    Type: Application
    Filed: August 7, 2017
    Publication date: June 13, 2019
    Inventors: Daniel GALLENKAMP, Mark James FORD
  • BET protein-inhibiting 5-aryltriazoleazepines
    Patent number: 9663523
    Abstract: The present invention relates to BET-protein-inhibitory, in particular BRD4-inhibitory 5-aryltriazoloazepines of the general formula (I) in which R1, R2, R3 and R4 have the meanings given for the general formula (I), to pharmaceutical compositions comprising the compounds according to the invention, and to the prophylactic and therapeutic use thereof for hyperproliferative disorders, especially for neoplastic disorders. The present invention further relates to the use of BET protein inhibitors in viral infections, in neurodegenerative disorders, in inflammatory diseases, in atherosclerotic disorders and in male fertility control.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: May 30, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Norbert Schmees, Joachim Kuhnke, Bernard Haendler, Roland Neuhaus, Pascale Lejeune, Stephan Siegel, Martin Krüger, Amaury Ernesto Fernandez-Montalvan, Hermann Künzer, Daniel Gallenkamp
  • BET-PROTEIN-INHIBITING DIHYDROPYRIDOPYRAZINONES
    Publication number: 20160193206
    Abstract: The present invention relates to BET protein-inhibitory, especially BRD4-inhibitory, dihydropyridopyrazinones of the general formula (I) in which A, X, R1, R2, R3, R4, R4, R6, R7 and n have the meanings given in the description, to intermediates for preparation of the compounds according to the invention, to pharmaceutical compositions comprising the compounds according to the invention, and to the prophylactic and therapeutic use thereof in the case of hyperproliferative disorders, especially in the case of neoplastic disorders. This invention further relates to the use of BET protein inhibitors in viral infections, in neurodegenerative disorders, in inflammation diseases, in atherosclerotic disorders and in male fertility control.
    Type: Application
    Filed: December 17, 2013
    Publication date: July 7, 2016
    Inventors: Norbert SCHMEES, Benjamin BADER, Bernard HAENDLER, Detlef STÖCKIGT, Pascale LEJEUNE, Amaury Ernesto FERNANDEZ-MONTALVAN, Timo STELLFELD, Daniel GALLENKAMP
  • MODIFIED BET-PROTEIN-INHIBITING DIHYDROQUINOXALINONES AND DIHYDROPYRIDOPYRAZINONES
    Publication number: 20160176867
    Abstract: The present invention relates to BET protein-inhibitory, especially BRD4-inhibitory, dihydroquinoxalinones and dihydropyridopyrazinones of the general formula (I) in which A, X, R1, R2, R3, R4, R5, R6 and n are each as defined in the description, to intermediates for preparation of the inventive compounds, to pharmaceutical compositions comprising the inventive compounds, and to the prophylactic and therapeutic use thereof in the case of hyperproliferative disorders, especially in the case of neoplastic disorders. This invention further relates to the use of BET protein inhibitors in viral infections, in neurodegenerative disorders, in inflammation diseases, in atherosclerotic disorders and in male fertility control.
    Type: Application
    Filed: July 7, 2014
    Publication date: June 23, 2016
    Inventors: Norbert SCHMEES, Bernard HAENDLER, Detlef STÖCKIGT, Daniel GALLENKAMP, Richard BISSELL, Richard Alexander BOUGLAS
  • BET-PROTEIN-INHIBITING DIHYDROXYQUINOXALINONES
    Publication number: 20150344444
    Abstract: The present invention relates to BET protein-inhibitory, especially BRD4-inhibitory, dihydroquinoxalinones of the general formula (I) in which A, X, R1, R2, R3, R4, R5, R6, R7 and n are each as defined in the description, to intermediates for preparation of the inventive compounds, to pharmaceutical compositions comprising the inventive compounds, and to the prophylactic and therapeutic use thereof in the case of hyperproliferative disorders, especially in the case of neoplastic disorders. This invention further relates to the use of BET protein inhibitors in viral infections, in neurodegenerative disorders, in inflammation disorders, in atherosclerotic disorders and in male fertility control.
    Type: Application
    Filed: December 17, 2013
    Publication date: December 3, 2015
    Inventors: Norbert SCHMEES, Bernard HAENDLER, Detlef STÖCKIGT, Daniel GALLENKAMP
  • BET PROTEIN-INHIBITING 5-ARYL TRIAZOLE AZEPINES
    Publication number: 20150299201
    Abstract: The present invention relates to BET-protein-inhibitory, in particular BRD4-inhibitory 5-aryltriazoloazepines of the general formula (I) in which R1, R2, R3 and R4 have the meanings given for the general formula (I), to pharmaceutical compositions comprising the compounds according to the invention, and to the prophylactic and therapeutic use thereof for hyperproliferative disorders, especially for neoplastic disorders. The present invention further relates to the use of BET protein inhibitors in viral infections, in neurodegenerative disorders, in inflammatory diseases, in atherosclerotic disorders and in male fertility control.
    Type: Application
    Filed: September 25, 2013
    Publication date: October 22, 2015
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Norbert Schmees, Joachim Kuhnke, Bernard Haendler, Roland Neuhaus, Pascale Lejeune, Stephan Siegel, Martin Krüger, Amaury Ernesto Fernandez-Montalvan, Hermann Künzer, Daniel Gallenkamp